Previous Close | 0.1350 |
Open | 0.1300 |
Bid | 0.1300 x 0 |
Ask | 0.1350 x 0 |
Day's Range | 0.1300 - 0.1400 |
52 Week Range | 0.0450 - 0.2400 |
Volume | 142,146 |
Avg. Volume | 819,409 |
Market Cap | 30.417M |
Beta (5Y Monthly) | 1.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0210 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Total voting support agreements for the Transaction now represent 44.4%, or 162.7 million, of the total votes outstanding including all senior management and board membersShareholders to benefit from a global platform of premium and super premium brands and distribution through Canada, Israel and EuropeThe Transaction has been approved by an MYM Special Committee of Independent Directors Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or ...
Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be immediately accretive to IMCHighland Grow is expected to generate net revenue of $29 million and $38 million and gross margins of 34% to 36% in 2021 and 2022, respectively[1]Purchase price implies 2.3x net revenue and 6.7x EBITDA in 2022 with synergiesMYM shareholders will receive 0.022 IMC shares for each MYM share, representing a price of $0.195 based on ...